Journey Medical (DERM) Other Non-Current Liabilities (2020 - 2023)
Journey Medical's (DERM) quarterly Other Non-Current Liabilities came in at $1.5 million in Q2 2023, down 60.87% YoY from $3.8 million in Q2 2022, and up 2.76% on a QoQ basis from $1.4 million in Q1 2023.
Journey Medical (DERM) Other Non-Current Liabilities (2020 - 2023) Analysis & Trends
Journey Medical (DERM) has 4 years of Other Non-Current Liabilities data on file, last reported at $1.5 million in Q2 2023.
- Quarterly Other Non-Current Liabilities fell 60.87% year-over-year to $1.5 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $1.5 million (down 60.87% YoY) and the FY2022 annual result came in at $1.4 million, down 61.07% from the prior year.
- Other Non-Current Liabilities improved to $1.5 million in Q2 2023, from $1.4 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $8.1 million in Q4 2020 to a low of $1.4 million in Q3 2022.
- A 4-year average of $3.3 million and a median of $3.6 million in 2021 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities plunged 55.43% — and 2022, when it tumbled 68.52%.
- Tracing DERM's Other Non-Current Liabilities over 4 years: stood at $8.1 million in 2020, then sank by 55.43% to $3.6 million in 2021, then plunged by 61.07% to $1.4 million in 2022, then climbed by 5.52% to $1.5 million in 2023.
- The last three Other Non-Current Liabilities figures came in at $1.5 million (Q2 2023), $1.4 million (Q1 2023), and $1.4 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.49 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 3.81 Mn |
| Mar 31, 2022 | 3.72 Mn |
| Dec 31, 2021 | 3.63 Mn |
| Sep 30, 2021 | 4.37 Mn |
| Dec 31, 2020 | 8.14 Mn |